These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7025374)

  • 1. Autolymphocytotoxic antibodies in patients on dialysis awaiting renal transplantation.
    Ettenger RB; Jordan S; Fine RN
    Transplantation; 1981 Sep; 32(3):248-51. PubMed ID: 7025374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity of autolymphocytotoxic antibodies from dialysis patients with lymphocytes from chronic lymphocytic leukemia (CLL) patients.
    Ting A; Morris PJ
    Transplantation; 1978 Jan; 25(1):31-3. PubMed ID: 339445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions and clinical significance of IgM and autoantibodies in highly sensitized renal allograft recipients.
    Vaidya S; Ruth J
    Transplantation; 1989 Jun; 47(6):956-8. PubMed ID: 2660358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of autoreactive lymphocytotoxic antibodies in sensitised dialysis and kidney transplant patients.
    Barocci S; Nocera A; Carozzi S; Leprini A; Fontana I; Armani R; Valente U; Lamperi S; Celada F
    Nephrol Dial Transplant; 1987; 2(4):266-70. PubMed ID: 2823188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific B and T lymphocyte antibodies and kidney graft survival.
    Jeannet M; Benzonana G; Arni I
    Transplantation; 1981 Mar; 31(3):160-3. PubMed ID: 7015609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to donor B lymphocytes and autoantibodies in renal transplantation.
    Ettenger RB; Robinson BJ; Uittenbogaart CH; Hacker TA; Pennisi AJ; Malekzadeh MH; Fine RN
    Transplant Proc; 1979 Mar; 11(1):401-3. PubMed ID: 377666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera. Race, transplant history, and HLA-DR1 phenotype.
    Barger B; Shroyer TW; Hudson SL; Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Diethelm AG
    Transplantation; 1989 Feb; 47(2):240-5. PubMed ID: 2645705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Test of differential anti-T and anti-B lymphocyte compatibility in renal transplantation. A partial solution to the problem of hyperimmune patients].
    Bignon JD; Soulillou JP; Hourmant M; Bretecher A; Moreau A; Guenel J
    Presse Med; 1983 Jul 9-16; 12(29):1801-5. PubMed ID: 6224194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilutions and specificity analysis of pretransplant sera.
    Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
    Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful transplantation with a positive T and B cell crossmatch due to autoreactive antibodies.
    Ting A; Morris PJ
    Tissue Antigens; 1983 Mar; 21(3):219-26. PubMed ID: 6222512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplant recipients with long incubation-positive antiglobulin-negative T cell crossmatches.
    Pettaway CA; Freeman C; Helderman JH; Stastny P
    Transplantation; 1987 Oct; 44(4):529-33. PubMed ID: 3313840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic antibodies to lymphocytes: relationship to sperm immunity.
    Mathur S; Williamson HO; Genco PV; Nesmith D; Rust PF; Fudenberg HH
    J Reprod Immunol; 1983 Mar; 5(2):89-100. PubMed ID: 6601706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant antibodies and renal allograft survival.
    MacLeod AM; Mason RJ; Power DA; Edward N; Stewart KN; Shewan G; Catto GR
    Proc Eur Dial Transplant Assoc; 1983; 20():305-8. PubMed ID: 6361743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive autologous crossmatches and a successful transplant with an HLA-identical, but not with an HLA-nonidentical, kidney.
    Radvany RM; Soper WD; Andersen RL; Wolf JS
    Transplantation; 1983 Dec; 36(6):654-8. PubMed ID: 6229072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossmatching with B and T cells and flow cytometry.
    Iwaki Y; Lau M; Cook DJ; Takemoto S; Terasaki PI
    Clin Transpl; 1986; ():277-84. PubMed ID: 3154417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful renal transplantation in patients with T-cell reactivity to donor.
    Cardella CJ; Falk JA; Nicholson MJ; Harding M; Cook GT
    Lancet; 1982 Dec; 2(8310):1240-3. PubMed ID: 6128547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in patients on dialysis awaiting renal transplantation.
    Ettenger RB; Robinson B; Louie J; Malekzadeh MH; Pennisi AJ; Jordan SC; Uittenbogaart CH; Fine RN
    Proc Clin Dial Transplant Forum; 1979; 9():205-8. PubMed ID: 399508
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoreactive lymphocytotoxic IgM antibodies in highly sensitized dialysis patients waiting for a kidney transplant: identification and clinical relevance.
    Barocci S; Valente U; Gusmano R; Perfumo F; Cantarella S; Leprini A; Icardi A; Nocera A
    Clin Nephrol; 1991 Jul; 36(1):12-20. PubMed ID: 1889147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis.
    Meijer CJ; Cnossen J; Lafeber GJ; Damsteeg MJ; Cats A
    Clin Exp Immunol; 1982 Feb; 47(2):368-80. PubMed ID: 6978781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadaver renal transplant outcome in recipients with autolymphocytotoxic antibodies.
    Ettenger RB; Jordan SC; Fine RN
    Transplantation; 1983 May; 35(5):429-31. PubMed ID: 6342221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.